Abeona Therapeutics Stock Market Value
| ABEO Stock | USD 6.39 0.02 0.31% |
| Symbol | Abeona |
Abeona Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.05) | Quarterly Revenue Growth (1.00) | Return On Assets (0.38) | Return On Equity (1.27) |
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Abeona Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Abeona Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Abeona Therapeutics.
| 06/04/2024 |
| 12/01/2024 |
If you would invest 0.00 in Abeona Therapeutics on June 4, 2024 and sell it all today you would earn a total of 0.00 from holding Abeona Therapeutics or generate 0.0% return on investment in Abeona Therapeutics over 180 days. Abeona Therapeutics is related to or competes with Reviva Pharmaceuticals, Athira Pharma, Fortress Biotech, ACADIA Pharmaceuticals, Cabaletta Bio, Affimed NV, and Checkpoint Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threaten... More
Abeona Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Abeona Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Abeona Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.5 | |||
| Information Ratio | 0.0431 | |||
| Maximum Drawdown | 12.28 | |||
| Value At Risk | (4.21) | |||
| Potential Upside | 4.31 |
Abeona Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abeona Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Abeona Therapeutics' standard deviation. In reality, there are many statistical measures that can use Abeona Therapeutics historical prices to predict the future Abeona Therapeutics' volatility.| Risk Adjusted Performance | 0.0806 | |||
| Jensen Alpha | 0.165 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.0448 | |||
| Treynor Ratio | 0.411 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abeona Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Abeona Therapeutics Backtested Returns
Abeona Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Abeona Therapeutics secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Abeona Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Abeona Therapeutics' mean deviation of 1.98, and Risk Adjusted Performance of 0.0806 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Abeona Therapeutics holds a performance score of 8. The firm shows a Beta (market volatility) of 0.58, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Abeona Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Abeona Therapeutics is expected to be smaller as well. Please check Abeona Therapeutics' potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to make a quick decision on whether Abeona Therapeutics' price patterns will revert.
Auto-correlation | 0.40 |
Average predictability
Abeona Therapeutics has average predictability. Overlapping area represents the amount of predictability between Abeona Therapeutics time series from 4th of June 2024 to 2nd of September 2024 and 2nd of September 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Abeona Therapeutics price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Abeona Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | 0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.14 |
Abeona Therapeutics lagged returns against current returns
Autocorrelation, which is Abeona Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Abeona Therapeutics' stock expected returns. We can calculate the autocorrelation of Abeona Therapeutics returns to help us make a trade decision. For example, suppose you find that Abeona Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Abeona Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Abeona Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Abeona Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Abeona Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Abeona Therapeutics Lagged Returns
When evaluating Abeona Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Abeona Therapeutics stock have on its future price. Abeona Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Abeona Therapeutics autocorrelation shows the relationship between Abeona Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Abeona Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Abeona Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abeona Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Abeona Stock
Moving against Abeona Stock
| 0.51 | ELAN | Elanco Animal Health | PairCorr |
| 0.5 | INAB | In8bio Inc | PairCorr |
| 0.41 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.32 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.31 | LTRN | Lantern Pharma | PairCorr |
The ability to find closely correlated positions to Abeona Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abeona Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abeona Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abeona Therapeutics to buy it.
The correlation of Abeona Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abeona Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abeona Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abeona Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Abeona Therapeutics Correlation, Abeona Therapeutics Volatility and Abeona Therapeutics Alpha and Beta module to complement your research on Abeona Therapeutics. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Abeona Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.